Enzotret 90mg/48mg/100mg Tablet is a combination pharmaceutical formulation containing Bromelain (90mg), Trypsin (48mg), and Rutoside (100mg). This synergistic blend is primarily indicated for the management of inflammatory conditions, edema, and tissue repair following trauma or surgical interventions. Bromelain, a proteolytic enzyme derived from pineapple stems, exhibits anti-inflammatory, anti-edematous, and fibrinolytic properties by modulating the inflammatory response and promoting the breakdown of fibrin. Trypsin, a serine protease enzyme, facilitates the degradation of necrotic tissue and enhances wound healing through its proteolytic activity. Rutoside, a bioflavonoid, contributes to vascular protection by strengthening capillary walls, reducing capillary permeability, and exerting antioxidant effects that mitigate oxidative stress in inflamed tissues. The combined action of these agents results in accelerated resolution of inflammation, decreased swelling, and improved microcirculation, making Enzotret suitable for conditions such as postoperative edema, sports injuries, phlebitis, and other inflammatory disorders. The tablet should be administered as prescribed by a healthcare professional, considering patient-specific factors and contraindications. Caution is advised in individuals with hypersensitivity to any component or underlying bleeding disorders. Regular monitoring and adherence to recommended dosage ensure optimal therapeutic outcomes and minimize adverse effects.